MET and non-small cell lung carcinoma: Thus, we transfected the ALK fusion‐positive NSCLC cell line H3122 with the METG1090A and the METY1230S mutations and confirmed these ALK fusion‐positive, MET mutant cell lines to be resistant to type I but not to type II MET, mimicking results we obtained in the HEK‐293T cell line (Figure S3).